ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756422 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756422; 2) Community: the network communities that were significantly associated with the response to NSC 756422; 3) Molecule: the relationships between components within communities and NSC 756422; 4) MDR: the compounds that were significantly associated with the NSC 756422.

NSC Compound Enrichment Correlation
NSC 693573 Null 0.0285477013888569 -0.24061633
NSC 700583 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0285477013888569 0.029295533
NSC 713019 Null 0.0285477013888569 -0.37597529
NSC 720057 5-(p-chlorobenzylidene)-3-phenyl-2-[(1-phenyl-3,5- dimethylpyrazol-4-yl)methylidenehydrazono]thiazolidin-4-one 0.0285477013888569 -0.058113709
NSC 729831 2-{4-[(1E)-3-pyridine-4-yltriaz-1-enyl]phenyl}-1H-benzimidaz ole 0.0285477013888569 0.052489698
NSC 731806 Null 0.0285477013888569 -0.11037814
NSC 736394 6-(3-Aminopropyl)-9-fluoro-5,6-dihydro-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline Hydrochloride 0.0285477013888569 0.0034340644
NSC 751548 Fluka catalog #46729 0.0285477013888569 -0.024705193
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0297837393005856 0.11924805
NSC 30915 Null 0.0297837393005856 0.38953016
Total:52  Current:29    [First] [Prev] [Next] [Last]